Cryo-EM in drug discovery
- PMID: 30647139
- DOI: 10.1042/BST20180267
Cryo-EM in drug discovery
Erratum in
-
Correction: Cryo-EM in drug discovery.Biochem Soc Trans. 2019 Feb 28;47(1):487. doi: 10.1042/BST-2018-0267C_COR. Biochem Soc Trans. 2019. PMID: 30819927 No abstract available.
Abstract
The impact of structural biology on drug discovery is well documented, and the workhorse technique for the past 30 years or so has been X-ray crystallography. With the advent of several technological improvements, including direct electron detectors, automation, better microscope vacuums and lenses, phase plates and improvements in computing power enabled by GPUs, it is now possible to record and analyse images of protein structures containing high-resolution information. This review, from a pharmaceutical perspective, highlights some of the most relevant and interesting protein structures for the pharmaceutical industry and shows examples of how ligand-binding sites, membrane proteins, both big and small, pseudo symmetry and complexes are being addressed by this technique.
Keywords: cryo-EM; drug discovery; pharmaceutical; structural biology.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous